Evidence map›Paper›PMID 25862671›Full record

ArticleAngiogenesis2015

Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury.

Scott M Moore, Hua Zhang, Nobuyo Maeda, Claire M Doerschuk, James E Faber

Open access · greenAbstract read
In one paragraph

Article in Angiogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 65 citations in OpenAlex.

  1. Coronary collaterals in patients with ST-elevation myocardial infarction presenting late after symptom onset.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Trial
  2. Genetic determinants of insufficiency of the collateral circulation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  3. Sanctuary sites in cortical stroke.Frontiers in neurology · 2025
    Article
  4. Large differences in collateral blood vessel abundance among individuals arise from multiple genetic variants.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Observational
  10. Assessment of microvascular rarefaction in human brain disorders using physiological magnetic resonance imaging.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  17. Observational
  18. High-altitude rodents have abundant collaterals that protect against tissue injury after cerebral, coronary and peripheral artery occlusion.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  19. Article
  20. Hypoxia induces de novo formation of cerebral collaterals and lessens the severity of ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Scott M MooreDepartment of Cell Biology and Physiology, 6309 MBRB, University of North Carolina, Chapel Hill, NC, 27599-7545, USA.
Hua Zhang
Nobuyo Maeda
Claire M Doerschuk
James E Faber
University of North Carolina at Chapel Hill · US

Funding

APOLIPOROTEIN GENES AND ATHEROGENESISR01HL042630 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 1989 to 2017
$4.9M
ALPHA ADRENOCEPTORS IN VASCULAR WALL GROWTHR01HL062584 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FABER, JAMES E · 1999 to 2011
$4.6M
Targeting the Pial Collateral Circulation for Mitigation of Cerebral IschemiaR01NS083633 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, HUA · 2013 to 2023
$4.5M
Mechanisms of Collateral Development and Collateral Growth in IschemiaR01HL090655 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FABER, JAMES E · 2008 to 2011
$2.0M
Maintenance and Rarefaction of the Native Collateral CirculationR01HL111070 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FABER, JAMES E · 2012 to 2015
$1.9M
NHLBI NIH HHS HL062584NHLBI NIH HHS HL090655NHLBI NIH HHS R01 HL042630NHLBI NIH HHS R01 HL062584NHLBI NIH HHS R01 HL090655NHLBI NIH HHS R01 HL111070NINDS NIH HHS R01 NS083633
6 · The paper itself

Abstract

rationaleCollaterals lessen tissue injury in occlusive disease. However, aging causes progressive decline in their number and smaller diameters in those that remain (collateral rarefaction), beginning at 16 months of age in mice (i.e., middle age), and worse ischemic injury-effects that are accelerated in even 3-month-old eNOS(-/-) mice. These findings have found indirect support in recent human studies.

objectiveWe sought to determine whether other cardiovascular risk factors (CVRFs) associated with endothelial dysfunction cause collateral rarefaction, investigate possible mechanisms, and test strategies for prevention. METHODS AND

resultsMice with nine different models of CVRFs of 4-12 months of age were assessed for number and diameter of native collaterals in skeletal muscle and brain and for collateral-dependent perfusion and ischemic injury after arterial occlusion. Hypertension caused collateral rarefaction whose severity increased with duration and level of hypertension, accompanied by greater hindlimb ischemia and cerebral infarct volume. Chronic treatment of wild-type mice with L-N (G)-nitro-arginine methylester caused similar rarefaction and worse ischemic injury which were not prevented by lowering arterial pressure with hydralazine. Metabolic syndrome, hypercholesterolemia, diabetes mellitus, and obesity also caused collateral rarefaction. Neither chronic statin treatment nor exercise training lessened hypertension-induced rarefaction.

conclusionChronic CVRF presence caused collateral rarefaction and worse ischemic injury, even at relatively young ages. Rarefaction was associated with increased proliferation rate of collateral endothelial cells, effects that may promote accelerated endothelial cell senescence.

Indexed as

AnimalsCardiovascular DiseasesCell ProliferationCollateral CirculationFemaleHindlimbImmunohistochemistryIschemiaMaleMiceMice, Inbred C57BLMice, TransgenicNeovascularization, PathologicNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIIPhysical Conditioning, AnimalNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIINos3 protein, mousepitavastatinQuinolinesRenin

Identifiers

PMID25862671
PMCPMC4475464
OpenAlexW2078768412

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.